Inventor · disambiguated record
Mi Young Cha
Also filed as: CHA MI YOUNG
12 granted patents·5 pending applications·93 citations·filing 2001–2022
90Inventor score
Files withBEIJING HANMI PHARMACEUTICAL CO LTD6GENOME & COMPANY3HANMI SCIENCE CO LTD3CHA MI YOUNG1HANMI HOLDINGS CO LTD1
Top patents by PatentIndex Score
17 records- 0188US8957065B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityCHA MI YOUNG·Filed 2011·Granted Feb 17, 2015·20 cites·27 claims
- 0285US9840517B2Compound inhibiting activities of BTK and/or JAK3 kinasesBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 12, 2017·12 cites·6 claims
- 0385US8003658B2Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereofHANMI HOLDINGS CO LTD·Filed 2005·Granted Aug 23, 2011·7 cites·11 claims
- 0483US10273242B2Compound inhibiting activities of BTK and/or JAK3 kinasesBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 30, 2019·6 cites·9 claims
- 0581US9345719B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2014·Granted May 24, 2016·4 cites·31 claims
- 0680US8188102B2Amide derivative for inhibiting the growth of cancer cellsLEE KWANG-OK·Filed 2008·Granted May 29, 2012·15 cites·4 claims
- 0780US6723724B2Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereofKOREA INST SCI & TECH·Filed 2001·Granted Apr 20, 2004·17 cites·8 claims
- 0876US7625926B2P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the sameHANMI PHARM IND CO LTD·Filed 2004·Granted Dec 1, 2009·9 cites·9 claims
- 0969USRE46511EFused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2011·Granted Aug 15, 2017·1 cites·54 claims
- 1066US10562902B2IRAK4 inhibitor and use thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2016·Granted Feb 18, 2020·2 cites·6 claims
- 1154US2024182563A1Anti-cntn4 antibody and use thereofGENOME & COMPANY·Filed 2022·Application pending·0 cites
- 1252US2016229868A1Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2016·Application pending·0 cites
- 1349US2024209112A1Anti-bcam antibody or antigen-binding fragment thereofGENOME & COMPANY·Filed 2021·Application pending·0 cites
- 1445US2024209081A1Anti-cntn4-specific antibodies and use thereofGENOME & COMPANY·Filed 2021·Application pending·0 cites
- 1534US10322108B2N-benzoate group substituted benzopyrroline-2-one derivative and use thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2016·Granted Jun 18, 2019·0 cites·14 claims
- 1632US2016340422A1Bifunctional fusion protein, preparation method therefor, and use thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
- 1727US10988482B2IRAK4 inhibitor and use thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 27, 2021·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Mi Young Cha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →